Search

Search Constraints

You searched for: Author/Creator Gupta, Veer

Search Results

1. A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort. Issue 1 (December 2017)

2. A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?. (January 2020)

3. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF. (19th July 2017)

4. Blood‐based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Issue 1 (18th November 2016)

5. Cerebral amyloid-β accumulation and deposition following traumatic brain injury—A narrative review and meta-analysis of animal studies. (May 2016)

6. Cerebrospinal fluid levels of fatty acid–binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individuals. Issue 1 (4th December 2022)

7. Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings. Issue 11 (1st February 2022)

8. Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges. Issue 1 (29th December 2015)

9. Computational refinement identifies functional destructive single nucleotide polymorphisms associated with human retinoid X receptor gene. Issue 4 (4th March 2023)

10. Decrease in p3‐Alcβ37 and p3‐Alcβ40, products of Alcadein β generated by γ‐secretase cleavages, in aged monkeys and patients with Alzheimer's disease. Issue 1 (1st January 2019)